Antonio Craxì Selected Research

Antonio Craxì Research Topics

Disease

63	Fibrosis (Cirrhosis) 07/2022 - 07/2002
41	Chronic Hepatitis C 01/2022 - 06/2002
29	Infections 01/2022 - 06/2002
27	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 07/2002
25	Liver Diseases (Liver Disease) 01/2022 - 07/2002
24	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 04/2003
20	Non-alcoholic Fatty Liver Disease 07/2022 - 05/2011
9	Chronic Hepatitis B 01/2019 - 01/2003
7	Chronic Hepatitis (Chronic Active Hepatitis) 02/2014 - 07/2002
6	Hepatitis 01/2022 - 10/2010
6	Fatty Liver 11/2021 - 10/2012
6	Hypertension (High Blood Pressure) 01/2020 - 10/2012
6	Insulin Resistance 11/2015 - 07/2008
6	Neoplasms (Cancer) 09/2015 - 04/2005
5	Inflammation (Inflammations) 01/2015 - 12/2010
4	Disease Progression 01/2021 - 01/2005
4	Iron Overload 10/2010 - 07/2004
3	Type 2 Diabetes Mellitus (MODY) 12/2020 - 01/2013
3	Hepatitis C 01/2018 - 09/2002
3	Crohn Disease (Crohn's Disease) 11/2016 - 12/2010
3	Autoimmune Hepatitis 01/2015 - 08/2010
3	Ascites 12/2013 - 09/2008
3	Liver Neoplasms (Liver Cancer) 03/2013 - 04/2005
3	Portal Hypertension 01/2012 - 10/2007
2	COVID-19 01/2021 - 01/2021
2	Virus Diseases (Viral Diseases) 12/2020 - 10/2010
2	Obesity 01/2019 - 11/2018
2	Hyperferritinemia 01/2019 - 05/2009
2	Necrosis 12/2014 - 01/2013
2	Thalassemia 05/2012 - 10/2010
2	Persistent Infection 05/2012 - 10/2006
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 08/2010 - 01/2003
2	Sclerosing Cholangitis 08/2010 - 01/2003
2	Body Weight (Weight, Body) 11/2006 - 09/2004
1	HIV Infections (HIV Infection) 01/2022
1	Metabolic Diseases (Metabolic Disease) 01/2021

Drug/Important Bio-Agent (IBA)

45	Antiviral Agents (Antivirals)IBA 01/2022 - 07/2002
26	Ribavirin (Virazole)FDA LinkGeneric 10/2018 - 09/2002
23	InterferonsIBA 12/2017 - 09/2002
8	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2005
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2003
8	Hepatitis B e AntigensIBA 01/2019 - 07/2002
7	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 06/2002
7	Biomarkers (Surrogate Marker)IBA 12/2020 - 07/2002
7	IronIBA 01/2019 - 07/2004
7	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 10/2014 - 01/2012
6	Alanine Transaminase (SGPT)IBA 07/2022 - 04/2009
6	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2002
6	telaprevirIBA 05/2014 - 01/2012
5	AlbuminsIBA 01/2022 - 09/2012
5	Pharmaceutical PreparationsIBA 01/2019 - 04/2011
5	Triglycerides (Triacylglycerol)IBA 01/2017 - 11/2010
5	Interferon-alpha (Interferon Alfa)IBA 11/2015 - 09/2002
5	Lamivudine (Epivir)FDA Link 01/2009 - 07/2002
4	CholesterolIBA 11/2021 - 05/2008
4	Ferritins (Ferritin)IBA 01/2019 - 05/2008
4	Sorafenib (BAY 43-9006)FDA Link 09/2015 - 03/2009
3	peginterferon alfa-2a (Pegasys)FDA Link 01/2019 - 02/2004
3	HDL CholesterolIBA 11/2018 - 11/2010
3	SofosbuvirIBA 01/2018 - 05/2014
3	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 01/2014
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2014 - 01/2012
3	Interferon alpha-2 (Roferon-A)FDA Link 09/2005 - 02/2004
2	glecaprevir and pibrentasvirIBA 06/2021 - 05/2021
2	VaccinesIBA 01/2021 - 05/2014
2	SodiumIBA 01/2020 - 12/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 01/2018
2	daclatasvirIBA 01/2019 - 01/2018
2	Ritonavir (Norvir)FDA Link 10/2018 - 01/2017
2	dasabuvirIBA 10/2018 - 01/2017
2	ombitasvirIBA 10/2018 - 01/2017
2	paritaprevirIBA 10/2018 - 01/2017
2	Transaminases (Aminotransferases)IBA 03/2016 - 12/2014
2	Vitamin D FDA LinkGeneric 01/2015 - 01/2012
2	FructoseIBA 03/2014 - 12/2013
2	LipidsIBA 01/2014 - 03/2012
2	BilirubinIBA 12/2013 - 09/2012
2	CreatinineIBA 12/2013 - 01/2013
2	LDL CholesterolIBA 10/2012 - 03/2012
2	TransferasesIBA 01/2012 - 08/2010
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2010 - 01/2009
2	Interleukin-10 (Interleukin 10)IBA 12/2010 - 07/2003
2	CytokinesIBA 12/2010 - 07/2003
2	EnzymesIBA 08/2009 - 04/2003
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	elbasvirIBA 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	atezolizumabIBA 01/2022
1	grazoprevirIBA 01/2022
1	fibroblast growth factor 21IBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021

Therapy/Procedure

47	Therapeutics 01/2022 - 07/2002
8	Liver Transplantation 01/2022 - 10/2004
2	Transplantation 05/2014 - 07/2002
2	Radiofrequency Ablation 01/2013 - 10/2009
2	Drug Therapy (Chemotherapy) 01/2012 - 07/2010
2	Chelation Therapy (Therapy, Chelation) 10/2010 - 08/2008
1	Blood Transfusion (Blood Transfusions) 01/2021
1	Tattooing 01/2021